News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,674 Results
Type
Article (40669)
Company Profile (269)
Press Release (676730)
Multimedia
Podcasts (76)
Webinars (17)
Section
Business (204562)
Career Advice (2018)
Deals (35504)
Drug Delivery (105)
Drug Development (81310)
Employer Resources (173)
FDA (16371)
Job Trends (14929)
News (346147)
Policy (32700)
Tag
Academia (2558)
Accelerated approval (23)
Adcomms (24)
Allergies (122)
Alliances (49573)
ALS (157)
Alzheimer's disease (1622)
Antibody-drug conjugate (ADC) (262)
Approvals (16553)
Artificial intelligence (453)
Autoimmune disease (114)
Automation (33)
Bankruptcy (361)
Best Places to Work (11638)
BIOSECURE Act (20)
Biosimilars (173)
Biotechnology (176)
Bladder cancer (143)
Brain cancer (51)
Breast cancer (586)
Cancer (4378)
Cardiovascular disease (358)
Career advice (1700)
Career pathing (34)
CAR-T (261)
CDC (44)
Celiac Disease (1)
Cell therapy (682)
Cervical cancer (34)
Clinical research (68985)
Collaboration (1462)
Company closure (4)
Compensation (1033)
Complete response letters (46)
COVID-19 (2693)
CRISPR (81)
C-suite (680)
Cystic fibrosis (135)
Data (5662)
Decentralized trials (2)
Denatured (25)
Depression (112)
Diabetes (455)
Diagnostics (6600)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (211)
Drug pricing (166)
Drug shortages (28)
Duchenne muscular dystrophy (209)
Earnings (89723)
Editorial (50)
Employer branding (21)
Employer resources (151)
Events (116553)
Executive appointments (936)
FDA (19103)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1317)
Gene editing (180)
Generative AI (38)
Gene therapy (537)
GLP-1 (911)
Government (4623)
Grass and pollen (6)
Guidances (375)
Healthcare (18858)
HIV (48)
Huntington's disease (39)
IgA nephropathy (75)
Immunology and inflammation (228)
Immuno-oncology (36)
Indications (75)
Infectious disease (2933)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (100)
Intellectual property (209)
Interviews (315)
IPO (16620)
IRA (48)
Job creations (3640)
Job search strategy (1427)
Kidney cancer (15)
Labor market (79)
Layoffs (541)
Leadership (28)
Legal (7941)
Liver cancer (88)
Longevity (12)
Lung cancer (605)
Lymphoma (347)
Machine learning (37)
Management (59)
Manufacturing (668)
MASH (152)
Medical device (13685)
Medtech (13722)
Mergers & acquisitions (19846)
Metabolic disorders (1136)
Multiple sclerosis (143)
NASH (16)
Neurodegenerative disease (276)
Neuropsychiatric disorders (69)
Neuroscience (2700)
NextGen: Class of 2025 (6518)
Non-profit (4501)
Now hiring (60)
Obesity (527)
Opinion (247)
Ovarian cancer (149)
Pain (173)
Pancreatic cancer (190)
Parkinson's disease (251)
Partnered (31)
Patents (444)
Patient recruitment (388)
Peanut (53)
People (58512)
Pharmaceutical (63)
Pharmacy benefit managers (26)
Phase I (21493)
Phase II (30367)
Phase III (22640)
Pipeline (3767)
Policy (260)
Postmarket research (2564)
Preclinical (9162)
Press Release (64)
Prostate cancer (214)
Psychedelics (43)
Radiopharmaceuticals (263)
Rare diseases (704)
Real estate (5948)
Recruiting (69)
Regulatory (23920)
Reports (51)
Research institute (2372)
Resumes & cover letters (351)
Rett syndrome (23)
RNA editing (12)
RSV (73)
Schizophrenia (134)
Series A (215)
Series B (165)
Service/supplier (11)
Sickle cell disease (91)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (40)
Startups (3606)
State (2)
Stomach cancer (16)
Supply chain (97)
Tariffs (80)
The Weekly (49)
Vaccines (944)
Venture capital (74)
Weight loss (340)
Women's health (74)
Worklife (17)
Date
Today (59)
Last 7 days (530)
Last 30 days (2315)
Last 365 days (30247)
2025 (29571)
2024 (35219)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (734)
Alabama (77)
Alaska (7)
Arizona (288)
Arkansas (13)
Asia (38930)
Australia (6362)
California (10362)
Canada (3084)
China (966)
Colorado (433)
Connecticut (445)
Delaware (306)
Europe (83916)
Florida (1535)
Georgia (330)
Hawaii (2)
Idaho (61)
Illinois (778)
India (54)
Indiana (490)
Iowa (20)
Japan (360)
Kansas (122)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1305)
Massachusetts (7474)
Michigan (301)
Minnesota (582)
Mississippi (5)
Missouri (120)
Montana (30)
Nebraska (26)
Nevada (112)
New Hampshire (73)
New Jersey (2796)
New Mexico (28)
New York (2763)
North Carolina (1353)
North Dakota (8)
Northern California (4970)
Ohio (305)
Oklahoma (20)
Oregon (38)
Pennsylvania (2124)
Puerto Rico (19)
Rhode Island (45)
South America (1100)
South Carolina (58)
South Dakota (1)
Southern California (4011)
Tennessee (162)
Texas (1595)
United States (37032)
Utah (306)
Vermont (1)
Virginia (237)
Washington D.C. (78)
Washington State (849)
West Virginia (4)
Wisconsin (89)
Wyoming (2)
717,674 Results for "oncotelic inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Emerging as Leader with New Independent JV Valuation
November 24, 2025
·
6 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) at Forefront of Effort to Optimize Next-Generation Cancer Therapies
October 31, 2025
·
3 min read
Press Releases
Oncotelic to Present at the LD Micro Main Event XIX
October 21, 2025
·
9 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Creating Pioneering Pipeline Designed to Transform Cancer, Rare Diseases Treatments
September 18, 2025
·
3 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
September 17, 2025
·
3 min read
Press Releases
Oncotelic Achieves Breakthrough $1.7 Billion Pipeline Valuation Through GMP Bio Joint Venture
November 21, 2025
·
5 min read
Press Releases
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
December 16, 2025
·
10 min read
Press Releases
Oncotelic Therapeutics and Sapu Bioscience Announce Publication on Sub-15 nm Nanoparticles in International Journal of Molecular Sciences
November 12, 2025
·
6 min read
Press Releases
Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
December 3, 2025
·
11 min read
Press Releases
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
December 5, 2025
·
11 min read
1 of 71,768
Next
